The table below shows Bolt Biotherapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$26.00K
$2.17M
$1.80M
$1.22M
$1.14M
$1.27M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$4.83M
$6.54M
$7.50M
$9.51M
$13.79M
$15.43M
SG&A
BOLT annual revenue (10-K history)
Bolt Biotherapeutics, Inc. reported annual revenue of $7.70M for fiscal year 2025. That is up 0.1% from $7.69M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $231.00K (FY 2020) to $7.70M. Figures come from the company's audited annual reports as filed with the SEC.